Michael Amoroso - Nov 2, 2024 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
President and CEO, Director
Signature
/s/ Dario Scimeca, Attorney-in-Fact for Michael Amoroso
Stock symbol
DTIL
Transactions as of
Nov 2, 2024
Transactions value $
-$24,668
Form type
4
Date filed
11/5/2024, 07:14 PM
Previous filing
Aug 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DTIL Common Stock Options Exercise +9.44K +42.72% 31.5K Nov 2, 2024 Direct F1, F2
transaction DTIL Common Stock Sale -$24.7K -3.01K -9.55% $8.19 28.5K Nov 4, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Restricted Stock Units Options Exercise $0 -9.44K -50% $0.00 9.44K Nov 2, 2024 Common Stock 9.44K Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting of Restricted Stock Units ("RSUs") on November 2, 2024.
F2 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3 The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.
F4 On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.